Opinion
Time for India to be firm with drugmakers rather than deregulate
Lax stance risks opportunity for 'friend-shoring' to serve Western nations
Pharmaceuticals
Pharmaceuticals
Japan's 1st abortion pill takes step closer to approval
Treatment would give women option other than surgical procedure
Pharmaceuticals
WHO urges 'immediate action' after cough syrup deaths
Contaminated over-the-counter medicines killed 300-plus children in 2022
Pharmaceuticals
Eisai's new Alzheimer's drug divides market watchers
Leqembi's price point spurs optimism after Aduhelm, but wide use unclear
Datawatch
COVID disrupts measles and other vaccinations in Asia, elsewhere
Pandemic saps resources to protect infants from contagious diseases
DealStreetAsia
Sequoia China-backed biopharma company files for $100m U.S. IPO
Structure Therapeutics developing drugs targeting a wide range of chronic diseases
Pharmaceuticals
Eisai files for Japan approval of Alzheimer's drug
Drugmaker's move follows U.S. application for full FDA approval
Pharmaceuticals
Novavax says COVID vaccines will be much like annual flu shots
Executive vice president wishes for a 'clear path' into China as demand wanes
Pharmaceuticals
Hopes for new Alzheimer's drug Leqembi lift Eisai shares
Lower cost could help spread use but better testing is key, analysts say
Pharmaceuticals
Pfizer says it could start making Paxlovid in China in 3-4 months
Company's COVID drug in high demand as infections spread following policy U-turn
Pharmaceuticals
Shionogi seeks to break away from China for COVID drug materials
Japanese company to revamp supply chain, turns to India and Japan for chemicals
Pharmaceuticals
New Alzheimer's drug Leqembi: Eisai, Biogen eye Japan, Europe and China next
FDA-approved treatment will save money spent on nursing care: Eisai CEO
COVID vaccines
Japan's Daiichi Sankyo to seek OK for omicron booster by April 2024
Shionogi and KM Biologics also eye homegrown shots targeting variants
Pharmaceuticals
Eisai and Biogen win FDA approval for latest Alzheimer's drug
U.S. authorization of Leqembi follows setbacks with Aduhelm
Business deals
Moderna snaps up Japan's OriCiro Genomics in mRNA manufacturing push
U.S. drugmaker sees promise in target company's technologies
Coronavirus
Japan's Shionogi seeks approval for COVID pill in South Korea
Drugmaker pursues first overseas authorization for Xocova treatment
Pharmaceuticals
Drugmaker Shionogi inks deal to market COVID pill in China
Agreement with Sino Bio unit comes a month after antiviral drug's approval in Japan
Pharmaceuticals
India probes cough syrup linked to Uzbekistan child deaths
Allegations echo Gambia scandal, casting new doubts on 'pharmacy of the world'
DealStreetAsia
Private equity company to buy majority stake in India's Suven Pharma
Advent actively investing in Indian companies
Coronavirus
China's COVID surge strains hospitals as estimated toll soars
Official count remains low, but country likely seeing 5,000 deaths a day
